150 related articles for article (PubMed ID: 34134908)
1. Human CD3
Min XY; Liu CF; Cao B; Zhang T; Yang X; Ma N; Wang N; Li K
Hum Immunol; 2021 Sep; 82(9):625-633. PubMed ID: 34134908
[TBL] [Abstract][Full Text] [Related]
2. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
3. Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer.
Peng LS; Mao FY; Zhao YL; Wang TT; Chen N; Zhang JY; Cheng P; Li WH; Lv YP; Teng YS; Guo G; Luo P; Chen W; Zou QM; Zhuang Y
Oncotarget; 2016 Aug; 7(34):55222-55230. PubMed ID: 27409423
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
[TBL] [Abstract][Full Text] [Related]
5. Altered effector function of peripheral cytotoxic cells in COPD.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2009 Jun; 10(1):53. PubMed ID: 19545425
[TBL] [Abstract][Full Text] [Related]
6. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.
Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
Hum Immunol; 2001 Oct; 62(10):1092-8. PubMed ID: 11600215
[TBL] [Abstract][Full Text] [Related]
7. Decline in peripheral blood NKG2D+CD3+CD56+ NKT cells in metastatic colorectal cancer patients.
Gharagozloo M; Rezaei A; Kalantari H; Bahador A; Hassannejad N; Maracy M; Nouri N; Sedghi M; Ghazanfari H; Bayat B
Bratisl Lek Listy; 2018; 119(1):6-11. PubMed ID: 29405723
[TBL] [Abstract][Full Text] [Related]
8. CD3
Sonkodi B; Pállinger É; Radovits T; Csulak E; Shenker-Horváth K; Kopper B; Buzás EI; Sydó N; Merkely B
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232420
[TBL] [Abstract][Full Text] [Related]
9. CD3
de Almeida SM; Beltrame MP; Tang B; Rotta I; Justus JLP; Schluga Y; da Rocha MT; Martins E; Liao A; Abramson I; Vaida F; Schrier R; Ellis RJ
J Neuroimmunol; 2023 Apr; 377():578067. PubMed ID: 36965365
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
11. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2010 Jun; 11(1):76. PubMed ID: 20540777
[TBL] [Abstract][Full Text] [Related]
12. The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma.
Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Bastiaannet E; Kuppen PJK; Hokland M
Cancer Immunol Immunother; 2020 Oct; 69(10):2009-2020. PubMed ID: 32399587
[TBL] [Abstract][Full Text] [Related]
13. The function of CD3+CD56+ NKT-like cells in HIV-infected individuals.
Jiang Y; Cui X; Cui C; Zhang J; Zhou F; Zhang Z; Fu Y; Xu J; Chu Z; Liu J; Han X; Liao C; Wang Y; Cao Y; Shang H
Biomed Res Int; 2014; 2014():863625. PubMed ID: 24779018
[TBL] [Abstract][Full Text] [Related]
14. Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.
Bojarska-Junak A; Hus I; Sieklucka M; Wasik-Szczepanek E; Mazurkiewicz T; Polak P; Dmoszynska A; Rolinski J
Oncol Rep; 2010 Sep; 24(3):803-10. PubMed ID: 20664990
[TBL] [Abstract][Full Text] [Related]
15. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
[TBL] [Abstract][Full Text] [Related]
16. CD8
Kumari S; Shivam P; Hansa J; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Hum Immunol; 2018 Aug; 79(8):616-620. PubMed ID: 29842895
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of complement receptors by human natural killer cells.
Min X; Liu C; Wei Y; Wang N; Yuan G; Liu D; Li Z; Zhou W; Li K
Immunobiology; 2014 Sep; 219(9):671-9. PubMed ID: 24775270
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients.
Wang H; Yang D; Xu W; Wang Y; Ruan Z; Zhao T; Han J; Wu Y
Immunol Lett; 2008 Oct; 120(1-2):65-71. PubMed ID: 18672004
[TBL] [Abstract][Full Text] [Related]
19. NKT-like cells reveal higher than T lymphocytes expression of cellular protective proteins HSP70 and SOD2 and comparably increased expression of SIRT1 in the oldest seniors.
Kaszubowska L; Foerster J; Kwiatkowski P; Schetz D
Folia Histochem Cytobiol; 2018; 56(4):231-240. PubMed ID: 30633320
[TBL] [Abstract][Full Text] [Related]
20. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
